Episode Synopsis "The Safety of Sodium Oxybate in Treating Narcolepsy "

Guest: Clete A. Kushida, MD, PhD Guest: Sally Ibrahim, MD, FAAP Sodium content and the disruption associated with the twice-nightly dosing of sodium oxybate are common concerns when treating patients with narcolepsy. Is sodium content truly a risk factor for cardiovascular sequelae in patients with narcolepsy? Does twice-nightly dosing lead to medically unacceptable dosing errors? Join Drs. Sally Ibrahim and Clete Kushida as they dive into these questions and provide actionable answers for you to use in your clinical practice.

Listen "The Safety of Sodium Oxybate in Treating Narcolepsy "

More episodes of the podcast Psychiatry and Mental Health

• The Safety of Sodium Oxybate in Treating Narcolepsy
• Setting the Stage: Unmet Needs in the Treatment of Women With PTSD
• Prevalence and Burden of PTSD in Women: Focus on Factors That Affect Patient Presentation, Such as Race, Risk Factors, Stigma, and Other Drivers
• Role of PCP & Ob-Gyn With Women at Risk for PTSD: Recognition, Screening, and Referral
• Proactively Uncovering Potential Traumatic Experiences Linked to Patient Psychiatric Symptoms in Women
• Conversations With Patients About PTSD, Screening, and Referral
• Inconsistent Outcomes: How Ignoring Guidelines Leads to Unpredictable Results
• Limitations of Current Treatments: FDA-Approved and Off-Label Approaches
• Pathophysiology and Pharmacologic Rationale of Emerging Agents for the Treatment of PTSD
• Profile and Role of Emerging Treatment Options: MOA, Safety and Efficacy, and Identifying the Patients Who May Benefit
• Modeling Activity: Quality Conversations With Patients About Suboptimal Management of PTSD Symptoms and Emerging Treatment Options